Legislative record

S 3203STATE · New YorkIn Committee

Preserves access to affordable drugs

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Voted 2/24/2026

Roll-call record

How representatives voted

122 yea·46 nay·9 other

Docket history

Action history

  1. 2/24/2026PASSED SENATE
  2. 2/24/2026DELIVERED TO ASSEMBLY
  3. 2/24/2026REFERRED TO HEALTH
  4. 2/11/2026ADVANCED TO THIRD READING
  5. 2/10/20262ND REPORT CAL.
  6. 2/9/20261ST REPORT CAL.304
  7. 1/7/2026DIED IN ASSEMBLY
  8. 1/7/2026RETURNED TO SENATE
  9. 1/7/2026REFERRED TO HEALTH
  10. 5/20/2025PASSED SENATE